SYNERCID Drug Patent Profile
✉ Email this page to a colleague
When do Synercid patents expire, and what generic alternatives are available?
Synercid is a drug marketed by King Pharms and is included in one NDA.
The generic ingredient in SYNERCID is dalfopristin; quinupristin. Additional details are available on the dalfopristin; quinupristin profile page.
Summary for SYNERCID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 1 |
Patent Applications: | 932 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SYNERCID |
What excipients (inactive ingredients) are in SYNERCID? | SYNERCID excipients list |
DailyMed Link: | SYNERCID at DailyMed |
Recent Clinical Trials for SYNERCID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Aventis Pharmaceuticals | Phase 3 |
Pfizer | Phase 3 |
US Patents and Regulatory Information for SYNERCID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms | SYNERCID | dalfopristin; quinupristin | INJECTABLE;INTRAVENOUS | 050748-001 | Sep 21, 1999 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms | SYNERCID | dalfopristin; quinupristin | INJECTABLE;INTRAVENOUS | 050748-002 | Aug 24, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |